SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Oxford GlycoSciences Plc

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Jongmans who started this subject4/24/2002 4:45:41 AM
From: nigel bates   of 469
 
Oxford Glycosciences PLC
24 April 2002

SCHEDULE 10

NOTIFICATION OF MAJOR INTERESTS IN SHARES

1) Name of company

Oxford GlycoSciences Plc

2) Name of shareholder having a major interest

Fidelity International Limited

3) Please state whether notification indicates that it is in respect of

holding of the shareholder named in 2 above or in respect of a

non-beneficial interest or in the case of an individual holder if it is a

holding of that person's spouse or children under the age of 18

Non-beneficial interest

4) Name of the registered holder(s) and, if more than one holder, the
number of shares held by each of them

Fidelity Investment Services Ltd:

Chase Nominees Ltd 8,480
Chase Manhattan Bank London 1,038,613
Fidelity Pension Management:
Chase Nominees Ltd 293,500
Bankers Trust 273,900
MSS Nominees Ltd 23,100
Fidelity International Ltd:
RBS Trust Bank 125,700
BT Globenet Nominees Ltd 56,500
Nortrust Nominees Ltd 107,800

Northern Trust 34,200
Chase Nominees Ltd 198,100
Chase Manhattan Bank London 70,536
Bank of New York London 15,400

5) Number of shares/amount of stock acquired

507,570

6) Percentage of issued class

0.91%

7) Number of shares/amount of stock disposed

N/A
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext